» Articles » PMID: 25923976

Screening and Treatment for Alcohol, Tobacco and Opioid Use Disorders: A Survey of Family Physicians Across Ontario

Overview
Journal PLoS One
Date 2015 Apr 30
PMID 25923976
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: As a primary point of contact within the health care system, family physicians are able to play a vital role in identifying individuals with substance use disorders and connecting them to the appropriate treatment. However, there is very little data available on whether family physicians are actively screening for and treating substance use disorders. The objective of the current survey was to assess whether family physicians in Ontario are screening for alcohol, opioid and tobacco use disorders, using validated tools and providing treatment.

Methods: An online survey consisting of a series of 38 primarily close-ended questions was circulated to family physicians in Ontario. Rates of screening for alcohol, opioid and tobacco dependence, use of validated tools for screening, providing treatment for dependent individuals and the current barriers to the prescription of pharmacotherapies for these drug dependences were assessed.

Results: The use of validated screening tools was limited for all three substances. Screening by family physicians for the substance use disorders among adolescents was much lower than screening among adults. Pharmacotherapy was more commonly used as an intervention for tobacco dependence than for alcohol and opioid dependence. This was explained by the lack of knowledge among family physicians on the pharmacotherapies for alcohol and opioid dependence.

Conclusions: Findings from the current study suggest there is a need for family physicians to integrate screening for substance use disorders using validated tools into their standard medical practice. Furthermore, there is a need for increased knowledge on pharmacotherapies for alcohol and opioid use disorders. It is important to note that the low response rate is a major limitation to this study. One possible reason for this low response rate may be a lack of interest and awareness among family physicians on the importance of screening and treatment of substance use disorders in Ontario.

Citing Articles

General dental practitioners' knowledge, attitudes and practice towards psychoactive substance use screening: A systematic review.

Fouillen K, Clement C, Aous E, Le Goff D, Le Reste J, Guillou-Landreat M Drug Alcohol Rev. 2025; 44(2):667-680.

PMID: 39888144 PMC: 11814361. DOI: 10.1111/dar.14002.


Physician Reluctance to Intervene in Addiction: A Systematic Review.

Campopiano von Klimo M, Nolan L, Corbin M, Farinelli L, Pytell J, Simon C JAMA Netw Open. 2024; 7(7):e2420837.

PMID: 39018077 PMC: 11255913. DOI: 10.1001/jamanetworkopen.2024.20837.


Recommending COVID-19 Vaccines to Patients: Practice and Concerns of Frontline Family Doctors.

Poon P, Zhou W, Chan D, Kwok K, Wong S Vaccines (Basel). 2021; 9(11).

PMID: 34835250 PMC: 8624411. DOI: 10.3390/vaccines9111319.


Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions.

Minian N, Noormohamed A, Lingam M, Zawertailo L, Le Foll B, Rehm J Addict Sci Clin Pract. 2021; 16(1):17.

PMID: 33726843 PMC: 7968293. DOI: 10.1186/s13722-021-00225-x.


Impact of a Web-Based Clinical Decision Support System to Assist Practitioners in Addressing Physical Activity and/or Healthy Eating for Smoking Cessation Treatment: Protocol for a Hybrid Type I Randomized Controlled Trial.

Minian N, Lingam M, Moineddin R, Thorpe K, Veldhuizen S, Dragonetti R JMIR Res Protoc. 2020; 9(9):e19157.

PMID: 32990250 PMC: 7556369. DOI: 10.2196/19157.


References
1.
McCabe S, Boyd C, Young A . Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health. 2006; 40(1):76-83. PMC: 1764616. DOI: 10.1016/j.jadohealth.2006.07.016. View

2.
Schwartz R, Wirtz P . Potential substance abuse. Detection among adolescent patients. Using the Drug and Alcohol Problem (DAP) Quick Screen, a 30-item questionnaire. Clin Pediatr (Phila). 1990; 29(1):38-43. DOI: 10.1177/000992289002900106. View

3.
Brands B, Blake J, Sproule B, Gourlay D, Busto U . Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004; 73(2):199-207. DOI: 10.1016/j.drugalcdep.2003.10.012. View

4.
Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J . Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009; 373(9682):2223-33. DOI: 10.1016/S0140-6736(09)60746-7. View

5.
Fischer B, Rehm J . Illicit opioid use and treatment for opioid dependence: challenges for Canada and beyond. Can J Psychiatry. 2006; 51(10):621-3. DOI: 10.1177/070674370605101001. View